Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken. Watch this short video to learn why!

Telemedicine Regulations for Buprenorphine Prescription

$49.99

Gain crucial insights into the expanded telemedicine regulations that allow practitioners to prescribe schedule III-V controlled substances for opioid use disorder treatment. Learn how to navigate these new rules, understand the necessary compliance steps, and the potential repercussions of non-compliance. This course equips you to effectively use telemedicine for OUD treatment, ensuring continuity of care.

In this course you will learn the following:
* Understand the scope and purpose of the new telemedicine regulations.
* Identify the key requirements for prescribing buprenorphine via telemedicine.
* Implement the necessary steps to comply with the regulations.
* Recognize the legal and financial repercussions of non-compliance.

Listen to a short Podcast discussing this course:

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year.  At the end of the one year term, the course will be set to “inactive”. 

Additional information

Federal Register Title

Expansion of Buprenorphine Treatment via Telemedicine Encounter. Document Number: 2025-01049

Course SKU

FR-25-509-1

Why This Course Is Important

Failing to understand and implement these telemedicine regulations can lead to legal penalties, loss of medical licenses, and hindered ability to provide continuous care for patients with opioid use disorder.